DV Medical Supply, Inc.

2000 W 135th Street
Gardena, CA. 90249
US

800-438-2568

Enalapril Maleate Tabs 10mg #1000
Enalapril Maleate Tabs 10mg #1000

Enalapril Maleate Tabs 10mg #1000

In Stock.
Part Number:DVM-100773
MPN:
Manufacturer: Wockhardt USA LLC

NDC:

64679-0925-03
You need to have an approved DV Med account to order this product.

INDICATIONS AND USAGE

Hypertension
Enalapril maleate is indicated for the treatment of hypertension.

Enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of enalapril maleate and thiazides are approximately additive.

Heart Failure
Enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. In these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see CLINICAL PHARMACOLOGY, HEART FAILURE, MORTALITY TRIALS for details and limitations of survival trials).

Asymptomatic Left Ventricular Dysfunction
In clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction =35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see CLINICAL PHARMACOLOGYHEART FAILUREMORTALITY TRIALS  for details and limitations of survival trials).

In using enalapril maleate consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril maleate does not have a similar risk (see WARNINGS, NEUTROPENIA/AGRANULOCYTOSIS).

In considering use of enalapril maleate it should be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. In addition, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks (see WARNINGS, HEAD AND NECK ANGIOEDEMA).

Related Items